Park Medi World Limited
All news and filings related to Park Medi World Limited.
View all news & filings- High impact
Park Medi World to Launch Panchkula Hospital, Expand Mohali Facility
Park Medi World will launch a new multispecialty hospital in Panchkula on March 29, 2026. The company will also add 150 beds to its Mohali facility, involving an investment of ₹40 crore. This expansion aims to bolster tertiary and quaternary care services, particularly in oncology and neurosciences.
Read the summary - High impact
Park Medi World to Launch Panchkula Hospital & Expand Mohali Facility
Park Medi World will launch a new multispecialty hospital in Panchkula on March 29, 2026, and expand its Mohali facility by adding 150 beds. These initiatives will increase the Tricity region's total bed capacity to 850, making it the largest private healthcare network. The Mohali expansion requires an investment of ₹40 crores.
Read the summary - Low impact
Park Medi World to Participate in Investor Session on March 14, 2026
Park Medi World Limited will participate in a virtual investor session organized by Divitiae Investments on March 14, 2026. The meeting will start at 11:30 a.m. onwards. No unpublished price-sensitive information will be discussed.
Read the summary - Low impact
Park Medi World to Hold Investor Meet on March 9, 2026
Park Medi World Limited will host an investor meet on March 9, 2026, involving physical facility visits and group/one-on-one meetings. The company will not disclose any unpublished price-sensitive information during the event.
Read the summary - Low impact
Park Medi World to Participate in Arihant Capital's Investor Conference on March 11, 2026
Park Medi World Limited will participate in the Arihant Bharat Connect Conference – Rising Stars 2026 on March 11, 2026. The virtual group meeting is organized by Arihant Capital. No unpublished price-sensitive information will be discussed.
Read the summary - Medium impact
Park Medi World Extends KP Institute Acquisition Deadline to March 31, 2026
Park Medi World Limited announced an extension for the acquisition of SVPD Healthcare Private Limited, a part of the KP Institute of Medical Sciences acquisition. The completion is now expected before March 31, 2026, following the acquisition of KPS Wellness Private Limited on January 30, 2026.
Read the summary - Low impact
Park Medi World IPO Proceeds Utilization: Monitoring Report for Q4 2025 Released
Park Medi World Limited's IPO proceeds utilization report for Q4 2025 shows ₹5,328.30 crore unutilized funds. During the quarter, ₹1,430.90 crore was used for loan repayment and ₹795.00 crore for acquisitions, including KP Institute of Medical Sciences and Krishna Super-speciality Hospital. Total IPO funds were ₹7,700 crore.
Read the summary - Low impact
Park Medi World Limited to Meet Investors/Analysts on Feb 16-17, 2026
Park Medi World Limited's management will meet investors and analysts during a roadshow in Mumbai on February 16-17, 2026. The meetings will be physical and may be one-on-one or group sessions. No unpublished price-sensitive information will be discussed.
Read the summary - Low impact
Park Medi World to Participate in Dam Capital Investor Conference on March 23
Park Medi World Limited will attend the DAM Capital Hospitals & Diagnostics conference in Mumbai on March 23, 2026. Management representatives will engage in one-to-one and group meetings. No unpublished price-sensitive information will be discussed.
Read the summary - Low impact
Park Medi World Limited to Participate in Dolat Capital's Corporate Conference on Feb 18, 2026
Park Medi World Limited will participate in Dolat Capital's "Corporate Conference 2026: Decoding Growth Strategies" in Mumbai on February 18, 2026. Management representatives will attend, and no Unpublished Price Sensitive Information will be discussed. The disclosure is available on the company's website.
Read the summary - High impact
Park Medi World Limited Releases Earnings Call Transcript for Q3 FY26
Park Medi World Limited released its Q3 FY26 earnings call transcript. Revenue for Q3 FY26 was ₹410 crore (18% YoY growth), and for nine months FY26 was ₹1218.9 crore (17% YoY growth). EBITDA margin was 24% for Q3 and 26% for nine months. The company plans to add 660 beds in FY26 and targets 5,260 beds by FY28. It expects to be debt-free by end of February.
Read the summary - Medium impact
Park Medi World Completes Acquisition of KPS Wellness, SVPD Healthcare Next
Park Medi World Limited has completed the acquisition of K P S Wellness Private Limited, making it a subsidiary. The company expects to finalize the acquisition of SVPD Healthcare Private Limited by February 28, 2026. This move is part of acquiring KP Institute of Medical Sciences.
Read the summary - Low impact
Park Medi World Limited: Earnings Conference Call Audio Recording Available
Park Medi World Limited has released the audio recording of its earnings conference call held on January 29, 2026. The call discussed the un-audited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025. The recording is available on the company's website.
Read the summary - Low impact
Park Medi World Limited Announces Newspaper Publication for Q3 FY26 Results
Park Medi World Limited announced the publication of its unaudited standalone and consolidated financial results for the quarter and nine months ending December 31, 2025. The notification was published on January 29, 2026, in Financial Express and Jansatta.
Read the summary - Medium impact
Park Medi World Releases Revised Q3 & 9M FY26 Investor Presentation
Park Medi World Limited released a revised investor presentation for Q3 & 9M FY26. Key acquisitions include Febris Multi-Speciality Hospital (₹245 crore) and KP Institute of Medical Sciences. Q3 FY26 revenues reached ₹410 crore with PAT of ₹52.8 crore. 9M FY26 revenues were ₹1,218.9 crore with PAT of ₹196.8 crore.
Read the summary - High impact
Park Medi World Q3 FY26: Revenue Up 17.76% to ₹410 Crore, PAT Jumps 15.78% to ₹52.8 Crore
Park Medi World Limited reported Q3 FY26 consolidated revenue of ₹410 crore, up 17.76% YoY. PAT increased by 15.78% to ₹52.8 crore. For 9M FY26, revenue grew 17.25% to ₹1,218.9 crore, and PAT surged 42.60% to ₹196.8 crore. The company also announced strategic acquisitions of two hospitals.
Read the summary - High impact
Park Medi World Q3 FY26 Revenue Up 18% to ₹410 Crore; Acquires 560 Beds
Park Medi World reported Q3 FY26 revenue of ₹410 crore, an 18% YoY increase. 9M FY26 revenue grew 17% to ₹1,218.9 crore. PAT for 9M FY26 rose 43% to ₹196.8 crore. The company acquired 560 beds through Febris Hospital and KP Institute of Medical Sciences, strengthening its North India footprint.
Read the summary - Low impact
Park Medi World Limited Authorizes Key Personnel for Disclosure Under SEBI Regulations
Park Medi World Limited, on January 28, 2026, authorized Mr. Rajesh Sharma, CFO, to determine the materiality of events and make disclosures to stock exchanges under Regulation 30 of SEBI Listing Regulations. Contact details were provided for Mr. Sharma. The disclosure will be available on the company website.
Read the summary - Medium impact
Park Medi World Approves Unaudited Results for Quarter and Nine Months Ended December 31, 2025
Park Medi World Limited's board approved unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025. IPO was completed for 56,790,123 equity shares at ₹162 per share. Acquisition of K P S Wellness and SVPD Healthcare for ₹24.50 crore (₹245 million) expected by February 28, 2026, and Krishna Super-Speciality Hospital for ₹4 crore (₹40 million) was approved on January 05, 2026.
Read the summary - Low impact
Park Medi World to Host Analyst Call on Jan 29 for Q3 FY26 Results
Park Medi World Limited will hold an analyst and institutional investor conference call on January 29, 2026, at 12:00 PM IST. The call will discuss the unaudited financial results for Q3 and the first nine months of FY26, ending December 31, 2025. Key management will participate.
Read the summary - Low impact
Park Medi World Files SEBI Reg 74(5) Certificate for Q3 FY26
Park Medi World Limited submitted a certificate under SEBI Regulation 74(5) for the quarter ended December 31, 2025. The certificate was issued by Registrar and Transfer Agent, Kfin Technologies Limited. It confirms compliance regarding dematerialization/rematerialization of securities.
Read the summary - Medium impact
Park Medi World Acquires Krishna Super-Speciality Hospital for ₹40 Crore
Park Medi World Limited acquired Krishna Super-Speciality Hospital for ₹40 crore in an all-cash deal. The 250-bedded hospital is located in Bathinda. This acquisition increases Park Group's bed capacity, aligning with their plan to reach 5,260 beds by March 2028.
Read the summary - High impact
Park Medi World Acquires Krishna Super-speciality Hospital for ₹40 Crore
Park Medi World Limited acquired Krishna Super-speciality Hospital for ₹40 crore. The 250-bedded hospital is owned by Mahip Hospitals Private Limited. This acquisition is part of Park Group's strategy to expand its bed capacity to 5,260 by March 2028. The deal was approved by the board on January 05, 2026.
Read the summary - Medium impact
Park Medi World Subsidiary Acquires Febris Multispeciality Hospital for ₹50.68 Crore
Park Medi World's subsidiary, Blue Heavens, acquired Febris Multispeciality Hospital for ₹50.68 crore. The 200-bedded hospital acquisition was completed on December 23, 2025, via the National Company Law Tribunal under insolvency proceedings. This move expands Park Group's capacity, supporting its goal of 5,260 beds by March 2028.
Read the summary - High impact
Park Medi World to Acquire KP Institute of Medical Sciences for ₹245 Crore
Park Medi World Limited will acquire KP Institute of Medical Sciences for ₹245 Crore in an all-cash deal. The acquisition of the 360-bed facility is expected to complete by February 28, 2026, strengthening Park Group's presence in North India.
Read the summary - High impact
Park Medi World to Acquire KP Institute of Medical Sciences for ₹245 Crore
Park Medi World Limited will acquire KP Institute of Medical Sciences (KPIMS) for ₹245 Crore in an all-cash deal. The acquisition of the 360-bed facility aligns with the company's growth strategy. The transaction is expected to be completed by February 28, 2026.
Read the summary
Model portfolios
Filings are the raw material. These are what SEBI-registered experts build from them.
- Stocks
Core Compounders
Companies that have already been through a downturn and came out still growing.
Moderate20 holdings3+ yearsView portfolio - Stocks
Udaan
Fast-growing, less-covered companies still early in their runway.
Aggressive29 holdings5+ yearsView portfolio - Stocks
Bharat Rising
Built around India's own shifts: capex, household savings, energy and consumption.
Moderate-Aggressive25 holdings3+ yearsView portfolio - Stocks
All-Terrain
One equity portfolio instead of three: large, mid and small cap in a single book.
Moderate-Aggressive34 holdings3+ yearsView portfolio